To access this element change to forms mode OFF
Grant Award View - GA59047
Developing innovative targeting strategies for diagnosis and treatment...
GA ID:
GA59047
Agency:
National Health and Medical Research Council (NHMRC)
Approval Date:
1-Aug-2019
Publish Date:
8-Oct-2019
Category:
Medical Research
Grant Term:
1-Jan-2020 to 31-Dec-2024
Value (AUD):
$2,751,754.59
(GST inclusive where applicable)
One-off/Ad hoc:
No
Aggregate Grant Award:
No
PBS Program Name:
NHMRC 19/20 1.1 Health and Medical Research
Grant Program:
Investigator
Grant Activity:
Developing innovative targeting strategies for diagnosis and treatment of cardiovascular and inflammatory diseases
Purpose:
Many diseases are diagnosed too late and treated with non-specific drugs, resulting in major side effects. I will use advanced biotechnology to develop innovative diagnostic tools and novel effective drugs without side effects. I will develop new anti-clotting drugs not causing bleeding, new therapies to prevent and treat heart attacks, and new anti-inflammatory and anti-cancer therapies. My work aims to improve outcomes and prevent diseases such as heart attack, multiple sclerosis and cancer.
GO ID:
GO Title:
Investigator Grants 2019
Internal Reference ID:
GNT1174098
Selection Process:
Targeted or Restricted Competitive
Confidentiality - Contract:
Yes
Confidentiality Reason(s) - Contract:
Privacy Act 1988
Intellectual property
Intellectual property
Confidentiality - Outputs:
Yes
Confidentiality Reason(s) - Outputs:
Intellectual property
Grant Recipient Details
Recipient Name:
Baker Heart and Diabetes Institute
Recipient ABN:
98 131 762 948
Grant Recipient Location
Suburb:
Melbourne
Town/City:
Melbourne
Postcode:
3004
State/Territory:
VIC
Country:
AUSTRALIA
Grant Delivery Location
State/Territory:
VIC
Postcode:
Country:
AUSTRALIA